| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9455 | 
      | Human Intestinal Absorption | HIA+ | 0.9726 | 
      | Caco-2 Permeability | Caco2+ | 0.6509 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8460 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9807 | 
                                                     | Non-inhibitor | 0.9784 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9145 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.5561 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8473 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8291 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.8163 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8951 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8978 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9754 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9515 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9850 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8328 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9621 | 
                                                                    | Non-inhibitor | 0.9663 | 
      | AMES Toxicity | Non AMES toxic | 0.9390 | 
      | Carcinogens | Carcinogens  | 0.6791 | 
      | Fish Toxicity | Low FHMT | 0.6292 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.7918 | 
      | Honey Bee Toxicity | High HBT | 0.7834 | 
      | Biodegradation | Ready biodegradable | 0.5258 | 
      | Acute Oral Toxicity | III | 0.5553 | 
      | Carcinogenicity (Three-class) | Non-required | 0.4947 |